Market Overview

UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Raises PT on Analog Devices on FY1Q13 EPS

Related ADI
Morgan Stanley: 'Surprise Uptick' In Short Interest Seen In Semiconductor Stocks
Nipro Medical Corporation Introduces The First Dialyzer In The US without BPA Or DEHP At The American Society Of Nephrology Kidney Week 2014
Making Money With Charles Payne: 08/28/14 (Fox Business)

In a report published Wednesday, BMO Capital Markets reiterated its Market Perform rating on Analog Devices (NASDAQ: ADI), and raised its price target from $41.00 to $45.00.

BMO Capital Markets noted, “ADI reported FY1Q13 EPS in line with our expectation of $0.44, with slightly lower revenues offset by higher GM and a lower tax rate. F1Q revenues were $622 million, down 10% q-q vs. our expectation of $632 million, down 9% q-q. For F2Q, at the midpoints, the company guided for revenues of $659 million, up 6% q-q, and EPS of $0.52. We had been expecting F2Q revenues of $670 million, up 6% q-q, and EPS of $0.53.”

Analog Devices closed on Tuesday at $47.01.

Latest Ratings for ADI

DateFirmActionFromTo
Oct 2014OppenheimerMaintainsOutperform
Oct 2014ISI GroupDowngradesBuyNeutral
Sep 2014JP MorganDowngradesOverweightNeutral

View More Analyst Ratings for ADI
View the Latest Analyst Ratings

Posted-In: BMO Capital MarketsAnalyst Color Price Target Analyst Ratings

 

Related Articles (ADI)

Around the Web, We're Loving...

Get Benzinga's Newsletters